The global robotics market will continue to be affected by China’s manufacturing slowdown and trade tensions with the U.S., says international analyst Georg Stieler as he looks ahead to 2020.
Verb Surgical debuts robot-assisted surgery prototype
Verb Surgical, Johnson & Johnson‘s (NYSE:JNJ) joint venture with Google parent Alphabet‘s (NSDQ:GOOGL) Verily Life Sciences, said today that it debuted its 1st digital surgery prototype to its collaboration partners at Ethicon Endo-Surgery and J&J. Robotic surgery, a fast growing field dominated by Intuitive Surgical (NSDQ:ISRG) and its da Vinci system, isn’t using robots yet, according to Verily CEO Andrew Conrad. In…